Patient expectations, experiences and satisfaction with nintedanib and pirfenidone in idiopathic pulmonary fibrosis: a quantitative study

Patient expectations, experiences and satisfaction with nintedanib and pirfenidone in idiopathic pulmonary fibrosis: a quantitative study

Abstract Background Two antifibrotic drugs, nintedanib and pirfenidone, are available for treatment of idiopathic pulmonary fibrosis (IPF). Although efficacy and adverse events have been well studied, little is known about patient experiences with these drugs. We aimed to systematically and quantita...

Full description

Bibliographic Details
Main Authors: C. C. Moor, R. L. M. Mostard, J. C. Grutters, P. Bresser, J. G. J. V. Aerts, C. D. Dirksen, M. L. Kimman, M. S. Wijsenbeek
Format: Article
Language:English
Published: BMC 2020-07-01
Series:Respiratory Research
Subjects:
Idiopathic pulmonary fibrosis
Patient-reported outcomes
Patient satisfaction
Medication
Patient experiences
Online Access:http://link.springer.com/article/10.1186/s12931-020-01458-1

Internet

http://link.springer.com/article/10.1186/s12931-020-01458-1

Similar Items